Patents by Inventor Robert T. Reese

Robert T. Reese has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5019511
    Abstract: Monoclonal antibodies are disclosed that react with an antigenic polypeptide having a molecular weight of approximately 45,000 that is expressed in the cell membrane of P. falciparun-infected erythrocytes. The antibodies were raised using the Honduras CDC isolate, and can be used for diagnostic purposes. The hybridoma producing the monoclonal antibodies is also disclosed.
    Type: Grant
    Filed: April 14, 1988
    Date of Patent: May 28, 1991
    Inventors: Robert T. Reese, Harold A. Stanley
  • Patent number: 5008198
    Abstract: The invention comprises antigenic glycoproteins substantially similar to antigenic glycoproteins present on the surface of the merozoite form of Plasmodium falciparum, including glycoproteins of molecular weights of about 56,000 present in the Geneva and FVO isolates and about 50,000 that is present in the Honduras I/CDC, Indochina 1, Kenya and Tanzania I isolates. The invention also comprises monoclonal antibodies 4-8-5D (HB 8938) which bind to the 56,000 glycoprotein of the invention, a hybridoma cell line that is capable of producing these monoclonal antibodies, and vaccines and vaccine compositions comprising these glycoproteins or epitopes substantially similar to or cross reactive with these glycoproteins or genes or gene fragments encoding such epitopes.
    Type: Grant
    Filed: May 30, 1989
    Date of Patent: April 16, 1991
    Assignee: Scripps Clinic and Research Foundation
    Inventors: Robert T. Reese, Harold A. Stanley
  • Patent number: 4978621
    Abstract: DNA sequences are described which encode Plasmodium falciparum merozoite antigenic surface proteins and protein fragments. Corresponding recombinant plasmids and transformed bacterial strains are described. The proteins and fragments have utility for immunological and diagnostic purposes.
    Type: Grant
    Filed: June 1, 1989
    Date of Patent: December 18, 1990
    Assignee: Scripps Clinic and Research Foundation
    Inventors: Feroza Ardeshir, Janette E. Flint, Robert T. Reese
  • Patent number: 4835259
    Abstract: The invention comprises antigenic glycoproteins substantially similar to antigenic glycoproteins present on the surface of the merozoite form of Plasmodium falciparum, including glycoproteins of molecular weights of about 56,000 and about 50,000. The invention also comprises monoclonal antibodies which bind to the glycoproteins of the invention, hybridoma cell lines which are capable of producing these monoclonal antibodies, and vaccines and vaccine compositions comprising these glycoproteins or epitopes substantially similar to or cross reactive with these glycoproteins or genes or gene fragments encoding such epitopes.
    Type: Grant
    Filed: September 14, 1984
    Date of Patent: May 30, 1989
    Assignee: Scripps Clinic and Research Foundation
    Inventors: Robert T. Reese, Randall F. Howard, Harold A. Stanley
  • Patent number: 4746612
    Abstract: Aotus trivirgatus interspecies hybridomas, their monoclonal receptors and methods of preparation and use are disclosed. The hybridomas are prepared by fusion of Aotus antibody-producing cells with myeloma cells containing about an equal number of chromosomes per cell. The resulting hybridomas are stable and secrete Aotus receptors. Particular receptors that immunoreact with antigenic proteins of Plasmodium falciparum shizonts and merozoites are disclosed.
    Type: Grant
    Filed: October 12, 1984
    Date of Patent: May 24, 1988
    Assignee: Scripps Clinic & Research Foundation
    Inventors: Harold A. Stanley, Robert T. Reese